Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 15 studies | 69% ± 18% | |
oligodendrocyte | 9 studies | 25% ± 9% | |
astrocyte | 7 studies | 34% ± 12% | |
pancreatic A cell | 3 studies | 32% ± 15% | |
GABAergic neuron | 3 studies | 26% ± 9% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 64% ± 20% | |
endothelial cell | 3 studies | 35% ± 14% | |
endocardial cell | 3 studies | 43% ± 7% | |
hepatocyte | 3 studies | 73% ± 27% | |
ependymal cell | 3 studies | 42% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 24% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 5333.09 | 226 / 226 | 94% | 49.75 | 383 / 406 |
brain | 99% | 3212.17 | 2617 / 2642 | 92% | 452.37 | 646 / 705 |
prostate | 98% | 4515.03 | 240 / 245 | 68% | 18.40 | 340 / 502 |
spleen | 100% | 4555.81 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 4077.35 | 1241 / 1335 | 0% | 0 | 0 / 0 |
thymus | 62% | 632.25 | 405 / 653 | 27% | 5.79 | 165 / 605 |
pancreas | 53% | 719.98 | 174 / 328 | 36% | 18.71 | 64 / 178 |
breast | 68% | 834.97 | 313 / 459 | 20% | 7.77 | 222 / 1118 |
muscle | 80% | 994.53 | 641 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 32% | 360.30 | 82 / 258 | 40% | 27.21 | 93 / 230 |
stomach | 33% | 281.52 | 118 / 359 | 32% | 13.22 | 91 / 286 |
adipose | 60% | 1450.20 | 717 / 1204 | 0% | 0 | 0 / 0 |
uterus | 20% | 320.53 | 34 / 170 | 34% | 24.45 | 156 / 459 |
skin | 31% | 304.57 | 560 / 1809 | 5% | 1.82 | 24 / 472 |
kidney | 20% | 207.02 | 18 / 89 | 13% | 9.64 | 114 / 901 |
bladder | 14% | 122.48 | 3 / 21 | 17% | 5.73 | 85 / 504 |
heart | 31% | 443.60 | 267 / 861 | 0% | 0 | 0 / 0 |
intestine | 2% | 14.85 | 18 / 966 | 25% | 8.35 | 131 / 527 |
lung | 1% | 3.93 | 3 / 578 | 26% | 11.55 | 298 / 1155 |
esophagus | 2% | 19.72 | 33 / 1445 | 16% | 4.83 | 30 / 183 |
ovary | 9% | 148.11 | 16 / 180 | 3% | 0.61 | 12 / 430 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.44 | 2 / 45 |
eye | 0% | 0 | 0 / 0 | 4% | 1.04 | 3 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.90 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060173 | Biological process | limb development |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0030154 | Biological process | cell differentiation |
GO_0045667 | Biological process | regulation of osteoblast differentiation |
GO_0001654 | Biological process | eye development |
GO_0005604 | Cellular component | basement membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0008201 | Molecular function | heparin binding |
GO_0050840 | Molecular function | extracellular matrix binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SMOC1 |
Protein name | SPARC-related modular calcium-binding protein 1 (Secreted modular calcium-binding protein 1) (SMOC-1) |
Synonyms | |
Description | FUNCTION: Plays essential roles in both eye and limb development. Probable regulator of osteoblast differentiation. . |
Accessions | Q9H4F8 ENST00000381280.4 [Q9H4F8-1] ENST00000361956.8 [Q9H4F8-2] |